Immunology · 1997 · 178 citations · 29 references
Veterinary MedicineImmunologyInfectious DiseasesInflammationInnate ImmunityNeuroimmunologyImmunoregulation In Parasitic InfectionInnate Immune Responses To ParasitesInnate Immunity To ParasitesInterferon ResponsesMalariaNeuroinflammationCerebral MalariaDisease-resistant AnimalsImmunopathology Of MalariaMalaria ImmunologyMalaria PathologyMalaria SusceptibilityNeurological PathogenesisNeutralization
In this study, we examined the effects of interleukin-10 (IL-10) on the outcome of experimental cerebral malaria (CM), a lethal neurological syndrome that occurs in susceptible strains of mice after infection with Plasmodium berghei ANKA (PbA). Constitutive IL-10 mRNA levels were significantly higher in the spleen and brain of resistant animals. In vivo neutralization of endogenous IL-10 in CM-resistant mice induced the neurological syndrome in 35.7% of these mice, as opposed to 7.7% in controls. IL-10 inhibited PbA antigen-specific interferon-gamma (IFN-gamma) production in vitro but not tumour necrosis factor (TNF) serum levels in vivo. Susceptible mice, on the other hand, were significantly protected against CM when injected with recombinant IL-10. Overall, our findings suggest that IL-10 plays a protective role against experimental cerebral malaria.
29
IL-10 inhibits cytokine production by activated macrophages
David Fiorentino, Albert Zlotnik, Tim R. Mosmann et al. · The Journal of Immunology · 1991 · 2.9K citations · Full text
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
David Fiorentino, Albert Zlotnik, Paulo Vieira et al. · The Journal of Immunology · 1991 · 1.9K citations · Full text
Interferon-γ: the Major Mediator of Resistance Against <i>Toxoplasma gondii</i>
Yasuhiro Suzuki, Manuel Orellana, Robert D. Schreiber et al. · Science · 1988 · 1.2K citations